European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Pierre Fabre Pharma GmbH, Freiburg i. Breisgau, Germany

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

Pierre Fabre Pharma GmbH

Identification

Ut
District Court of Freiburg HRB 2728
EUID
DEB8536.HRB2728

Address

Neuer Messplatz 5, 79108 Freiburg i. Breisgau, Germany

Corporate purpose

The conduct of business with commercial and financial activities, including import, export, promotion, manufacture, marketing, distribution and sale of pharmaceutical products, in particular pharmaceuticals, medical devices and dietary supplements as well as related products and services in Germany and abroad.

Financials

Employees

For this company, Employees numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Network

Loading network
CSV export

Investigative Journalism

Uncover International Corporate Connections with our Free Investigative-Account

Publications

25 Aug 2025
Annual report for the year ending 31/12/2024 · Balance sheet for 31/12/2024 · Earnings statement for 31/12/2024
21 Jul 2025
Managing Director: Axel Kaaß · Authorized signatory (ppa): Kai M. Neckermann, Hauke Voß · No longer Managing Director: Hauke Voß, Frédérike Podevin · No longer Authorized signatory (ppa): Axel Kaaß
31 Mar 2025
Annual report for the year ending 31/12/2023 · Balance sheet for 31/12/2023 · Earnings statement for 31/12/2023
2 Jan 2025
Managing Director: Hauke Voß · No longer Authorized signatory (ppa): Daniel Scholz · Proxy policy
1 Jul 2024
Annual report for the year ending 31/12/2022 · Balance sheet for 31/12/2022 · Earnings statement for 31/12/2022
29 Jan 2024
Authorized signatory (ppa): Daniel Scholz
3 Jan 2024
Managing Director: Pierre-E. Liraud, Frédérike Podevin · Authorized signatory (ppa): Axel Kaaß · No longer Managing Director: Guillaume A. Tamet
20 Jun 2023
Annual report for the year ending 31/12/2021 · Balance sheet for 31/12/2021 · Earnings statement for 31/12/2021
24 May 2023
Managing Director: Frédérike Podevin · Authorized signatory (ppa): Axel Kaaß · No longer Managing Director: Pascal Voltzenlugel · No longer Authorized signatory (ppa) (1)
22 Jul 2022
Managing Director: Pascal Voltzenlugel · Address
20 Jul 2022
Original document: “Liste der Gesellschafter“
22 Feb 2022
Annual report for the year ending 31/12/2020 · Balance sheet for 31/12/2020 · Earnings statement for 31/12/2020
30 Dec 2021
Authorized signatory (ppa): Daniel Scholz
8 Dec 2021
Authorized signatory (ppa): Daniel Scholz
17 Feb 2021
Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019 · Earnings statement for 31/12/2019
3 Dec 2020
Managing Director: Guillaume A. Tamet · No longer Managing Director: V. Guiraud-Chaumeil · Authorized signatory (ppa) (1) · No longer Authorized signatory (ppa) (1)
19 Feb 2020
Annual report for the year ending 31/12/2018 · Balance sheet for 31/12/2018 · Earnings statement for 31/12/2018
21 Feb 2019
Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017 · Earnings statement for 31/12/2017
5 Nov 2018
Authorized signatory (ppa) (1) · No longer Authorized signatory (ppa) (1)
12 Apr 2018
Annual report for the year ending 31/12/2016 · Balance sheet for 31/12/2016 · Earnings statement for 31/12/2016
9 Mar 2017
Annual report for the year ending 31/12/2015 · Balance sheet for 31/12/2015 · Earnings statement for 31/12/2015
5 Dec 2016
Address · Share­holder agreement · Corporate Purpose
25 Oct 2016
Original document: “Liste der Gesellschafter“
25 Oct 2016
Original document: “Gesellschaftsvertrag / Satzung / Statut“
3 Aug 2016
Managing Director: Pascal Voltzenlugel · No longer Managing Director: Marc Vincenti · No longer Authorized signatory (ppa) (1)
29 Feb 2016
Annual report for the year ending 31/12/2014 · Balance sheet for 31/12/2014 · Earnings statement for 31/12/2014
22 Sept 2015
Authorized signatory (ppa) (1)
Year 2015 in Dpmam
4 trademark filings: Diaphal, Osteogenon, Silino, TARDYFERON
16 Mar 2015
Annual report for the year ending 31/12/2013 · Balance sheet for 31/12/2013 · Earnings statement for 31/12/2013
21 Feb 2014
Managing Director: Marc Vincenti · No longer Managing Director (1)
5 Dec 2013
Annual report for the year ending 31/12/2012 · Balance sheet for 31/12/2012 · Earnings statement for 31/12/2012
8 Feb 2013
Annual report for the year ending 31/12/2011 · Balance sheet for 31/12/2011 · Earnings statement for 31/12/2011
30 Jul 2012
Managing Director (2) · No longer Authorized signatory (ppa) (1)
2 Feb 2012
Annual report for the year ending 31/12/2010 · Balance sheet for 31/12/2010 · Earnings statement for 31/12/2010
17 Oct 2011
Managing Director: V. Guiraud-Chaumeil · No longer Managing Director (1)
20 Dec 2010
Annual report for the year ending 31/12/2009 · Balance sheet for 31/12/2009 · Earnings statement for 31/12/2009
13 Dec 2010
Managing Director (1) · Authorized signatory (ppa) (2) · No longer Managing Director (1)
3 Mar 2010
Annual report for the year ending 31/12/2008 · Balance sheet for 31/12/2008 · Earnings statement for 31/12/2008
9 Mar 2009
Annual report for the year ending 31/12/2007 · Balance sheet for 31/12/2007 · Earnings statement for 31/12/2007
3 Nov 2008
Managing Director (1) · No longer Managing Director (1)
9 Jun 2008
Managing Director (1) · No longer Managing Director (1)
21 Apr 2008
Managing Director (1) · No longer Managing Director (1)
8 Apr 2008
Annual report for the year ending 31/12/2006 · Balance sheet for 31/12/2006 · Earnings statement for 31/12/2006
1 Aug 2007
Wordmark: “Steoporon“
1 Aug 2007
Wordmark: “Steoporos“
22 Mar 2006
Managing Director (1)
15 Mar 2006
Reg­is­tra­tion · Managing Director (1) · ppa (1) · Capital: 500,000 DEM · Seat: Freiburg im Breisgau · Legal form · Name: Pierre Fabre Pharma GmbH · Proxy policy · Corporate Purpose
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Creative Commons License The visualizations for "Pierre Fabre Pharma GmbH, Freiburg i. Breisgau, Germany" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.